IP Library Granted Patent US 11,299,784
Granted Patent B2
US 11,299,784 · App. 16/304,758 · Granted Apr 12, 2022

Biomarkers for predicting degree of weight loss

Inventors: Armand Valesia (Chavannes-pres-Renens, CH); Jorg Hager (Houtaud, FR); Jerome Carayol (Pully, CH)
Assignee: Societe des Produits Nestle S.A.
C12Q1/6883G16B5/00G16B20/20G16B40/10G16H50/20G16H50/30G16H50/70C12Q2600/156C12Q2600/158C12Q2600/178
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,299,784
App. No.
16/304,758
Granted
Apr 12, 2022
Kind
B2
Abstract

The present invention relates to a method for predicting the degree of weight loss attainable by applying one or more dietary interventions to a subject and/or the degree of maintenance of weight loss following one or more dietary interventions; which method comprises determining the level of microRNA-486 (miR-486) in one or more samples obtained from the subject; and/or determining the nucleotide of the subject at one or more polymorphic positions genetically linked to miR-486.

Claims (7)

1. A method for weight loss in a human, the method comprising:

(a) determining a presence of Guanine (G) at position 26 of SEQ ID NO: 3 (rs545936) of the human; and

(b) administering a dietary intervention to the human having a G at position 26 of SEQ ID NO: 3 (rs545936), wherein the dietary intervention comprises a low calorie diet comprising a calorie intake of 600-1200 kcal/day for a duration of 4 weeks to 16 weeks.

2. The method according to claim 1 , wherein the method further comprises determining one or more anthropometric measures and/or lifestyle characteristics of the subject.

3. A method for improvement in glycemic control in a human, the method comprising:

(a) determining a presence of Guanine (G) at position 26 of SEQ ID NO: 3 (rs545936) of the human; and

(b) administering a dietary intervention to the human having a G at position 26 of SEQ ID NO: 3 (rs545936), wherein the dietary intervention comprises a low calorie diet comprising a calorie intake of 600-1200 kcal/day for a duration of 4 weeks to 16 weeks.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2019
From: VALSESIA, ARMAND; HAGER, JORG; CARAYOL, JEROME
To: NESTEC S.A.
Reel/Frame 049914/0703 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →